|
?:authorAffiliation
|
-
[\'Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Innovation & Supply Chain Pandemic REPROGRAM Study Group, Sydney, NSW, Australia.\', \'Department of Neurology & Neurophysiology, Liverpool Hospital and South Western Sydney Local Health District, Liverpool, NSW, Australia.\', \'Neurovascular Imaging Laboratory, Clinical Sciences Stream and NSW Brain Clot Bank, Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.\', \'UNSW Medicine, South Western Sydney Clinical School, The University of New South Wales, Sydney, NSW, Australia.\', \'Innovation, Technology Entrepreneurship and Marketing (ITEM) Group, Eindhoven University of Technology, Eindhoven, Netherlands.\', \'Department of Food and Resource Economics, University of Copenhagen, Copenhagen, Denmark.\', \'Garwood Center for Corporate Innovation, University of California, Berkeley, Berkeley, CA, United States.\', \'Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, Denmark.\', \'Faculty of Law, Lund University, Lund, Sweden.\', \'College of Health and Human Development, Penn State University, State College, PA, United States.\', \'Department of Neurology, Movement Disorders Institute, Sheba Medical Center, Ramat Gan, Israel.\', \'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Maire Tecnimont Professor of Open Innovation, Luiss University, Rome, Italy.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}